This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers’ 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers’ regulatory 13F Form filed on 01/29/2019. Please visit our Tracking Kahn Brothers Portfolio series to get an idea of their investment philosophy and our last update for the fund’s moves during Q3 2018.
This quarter, Kahn Brothers’ 13F portfolio value decreased ~15% from $651.2M to $554.7M. The number of holdings remained steady at 31. The largest individual stock position is Merck which accounts